These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7694644)

  • 1. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity.
    Metzler B; Wraith DC
    Int Immunol; 1993 Sep; 5(9):1159-65. PubMed ID: 7694644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis.
    Metzler B; Wraith DC
    Ann N Y Acad Sci; 1996 Feb; 778():228-42. PubMed ID: 8610976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions.
    Metzler B; Wraith DC
    Immunology; 1999 Jun; 97(2):257-63. PubMed ID: 10447740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
    Lamont AG; Sette A; Fujinami R; Colón SM; Miles C; Grey HM
    J Immunol; 1990 Sep; 145(6):1687-93. PubMed ID: 1697306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction.
    Fairchild PJ; Wildgoose R; Atherton E; Webb S; Wraith DC
    Int Immunol; 1993 Sep; 5(9):1151-8. PubMed ID: 7694643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-Au.
    Gautam AM; Pearson CI; Sinha AA; Smilek DE; Steinman L; McDevitt HO
    J Immunol; 1992 May; 148(10):3049-54. PubMed ID: 1578131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.
    Fugger L; Liang J; Gautam A; Rothbard JB; McDevitt HO
    Mol Med; 1996 Mar; 2(2):181-8. PubMed ID: 8726461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a heterogeneous TCR repertoire in (PL/JXSJL/J)F1 mice by myelin basic protein peptide Ac1-11 and its analog Ac1-11[4A].
    Pearson CI; Smilek DE; Danska JS; McDevitt HO
    Mol Immunol; 1997 Aug; 34(11):781-92. PubMed ID: 9444977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
    Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
    J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein.
    Sakai K; Zamvil SS; Mitchell DJ; Lim M; Rothbard JB; Steinman L
    J Neuroimmunol; 1988 Aug; 19(1-2):21-32. PubMed ID: 2456304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.
    Wraith DC; Smilek DE; Mitchell DJ; Steinman L; McDevitt HO
    Cell; 1989 Oct; 59(2):247-55. PubMed ID: 2478291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.
    Smilek DE; Wraith DC; Hodgkinson S; Dwivedy S; Steinman L; McDevitt HO
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9633-7. PubMed ID: 1719536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ; Kennedy MK; Miller SD
    J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity.
    Liu GY; Wraith DC
    Int Immunol; 1995 Aug; 7(8):1255-63. PubMed ID: 7495732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.
    Zamvil SS; Mitchell DJ; Moore AC; Schwarz AJ; Stiefel W; Nelson PA; Rothbard JB; Steinman L
    J Immunol; 1987 Aug; 139(4):1075-9. PubMed ID: 2440944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.
    Gautam AM; Lock CB; Smilek DE; Pearson CI; Steinman L; McDevitt HO
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):767-71. PubMed ID: 7507253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
    J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.